Join the Frontline with FOMAT’s Colorectal Cancer Clinical Trials

Learn More

FOMAT Medical Research is deeply committed to advancing colorectal cancer (CRC) research through rigorous clinical trials. Colorectal Cancer Clinical trials are crucial in discovering new treatments, improving prevention methods, and understanding CRC better. FOMAT is dedicated to discovering innovative treatments and prevention methods for CRC, highlighting recent advancements in CRC treatment, including breakthroughs in surgery, chemotherapy, and immunotherapy.

Understanding Colorectal Cancer (CRC)

Colorectal cancer (CRC) refers to cancers that start in the colon or rectum. It is a significant health concern due to its prevalence and impact on mortality. The scope and purpose of CRC research aim to improve diagnosis, treatment, and prevention of CRC, ultimately reducing its burden on individuals and healthcare systems. CRC affects numerous individuals worldwide, with risk factors including age, family history, lifestyle, and genetic predispositions.

Symptoms and Progression of Colorectal Cancer

Common symptoms associated with CRC include changes in bowel habits, blood in stool, and abdominal discomfort. Understanding the progression of CRC, including its complications like metastasis, underscores the importance of early detection and screening for improved outcomes.

Gastrointestinal Clinical Trials

Causes and Risk Factors

Potential causes and risk factors for CRC include age, family history, diet and lifestyle, genetic predisposition, and inflammatory bowel disease. Addressing these factors is essential for prevention and early intervention.

Complications of CRC

Early detection and intervention are crucial to prevent complications such as bowel obstruction, metastatic disease, and treatment-related side effects. These complications significantly impact patient prognosis and quality of life, highlighting the importance of comprehensive care.

About CRC in Colorectal Cancer Clinical Trials

Is there a Clinical Trial for Rectal Cancer?

Numerous clinical trials are available for individuals diagnosed with colon cancer, focusing on various aspects of treatment and management. Individuals can find relevant clinical trials through medical providers, research institutions, and dedicated platforms like ClinicalTrials.gov.

Key Areas of Focus in Colorectal Cancer Clinical Trials

Understanding how CRC tumors grow and spread is essential for developing effective treatments. Clinical trials focus on various aspects such as tumor growth and metastasis, treatment modalities including surgery, chemotherapy, and radiation, side effects and management strategies, and quality of life considerations.

Why Clinical Trials Are Crucial for CRC Research

Current challenges in diagnosing and managing CRC include limited treatment options for advanced stages and the development of resistance to existing therapies. Clinical trials are vital for addressing these issues, exploring personalized medicine approaches, and advancing the role of immunotherapy and targeted therapies.

Frequently Asked Questions

The duration of a clinical trial is influenced by numerous factors, including the nature of the illness and the specific medication under investigation. For instance, clinical trials focused on treatments for chronic conditions often require long-term monitoring of participants' progress. Conversely, studies involving antibiotics tend to be brief, as these medications usually require only a few days of treatment for the patients involved.

Depending on the study and the study process, in some cases, you will have to keep track of your process, in other cases you will not, but you will have the support and guidance of the research team.

As a research participant, you have the right to drop out of a study at any time, the right to be given new information about the study, and the right to ask questions at any time and have them answered promptly.

Yes. Although the purpose of the study is not to treat an individual for any health condition, a study may involve clinical procedures such as an MRI, blood tests, hearing tests, etc. In order to complete these and other tests, the researcher must know the volunteer's general state of health to ensure his or her safety during the clinical study process.

No, you do not have to be a US citizen to participate in a clinical trial. We also do not ask for your social security number. All we ask is that you have a physical address and some form of ID that we can use during the enrollment process.

Sure, you can refer any friend or family member who is willing to participate in a study, for more information click here!

Who is FOMAT Medical Research?

FOMAT Medical Research is California's largest research site network, dedicated to advancing clinical research and improving patient outcomes. With an extensive network of research sites and a relentless commitment to innovating healthcare through diversity, FOMAT Medical Research collaborates with industry Sponsors and CROs to accelerate the development of groundbreaking therapies across multiple therapeutic areas. FOMAT is a founding member of hyperCORE International, a super network of fully professionalized research site organizations.

FOMAT's Commitment to CRC Research

FOMAT Medical Research is deeply committed to advancing colorectal cancer (CRC) research through rigorous clinical trials. FOMAT's expertise in conducting clinical trials related to CRC demonstrates the company's dedication to advancing knowledge about CRC. Highlighting previous or ongoing CRC-related clinical trials showcases FOMAT's commitment to the field.

Check Our Capabilities!

Meet Our Experts

Karen Simon, M.D.

Karen Simon, MD

Gastroenterologist
Centered Icon and Text
Camarillo & Oxnard, CA
Elias Tarakji, MD

Elias A. Tarakji, MD

Gastroenterologist
Centered Icon and Text
Arcadia, CA
Keval Shah, D.O.

Dr. Keval Shah, DO

Gastroenterologist
Centered Icon and Text
Santa Maria, CA
Meet Our Medical Experts